RU2002100067A - VIIA FACTOR INHIBITORS - Google Patents
VIIA FACTOR INHIBITORSInfo
- Publication number
- RU2002100067A RU2002100067A RU2002100067/04A RU2002100067A RU2002100067A RU 2002100067 A RU2002100067 A RU 2002100067A RU 2002100067/04 A RU2002100067/04 A RU 2002100067/04A RU 2002100067 A RU2002100067 A RU 2002100067A RU 2002100067 A RU2002100067 A RU 2002100067A
- Authority
- RU
- Russia
- Prior art keywords
- alkyl
- aryl
- het
- group
- groups
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title claims 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 21
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims 12
- -1 acetylamino- Chemical class 0.000 claims 12
- 229910052739 hydrogen Inorganic materials 0.000 claims 12
- 239000001257 hydrogen Substances 0.000 claims 12
- 150000001875 compounds Chemical class 0.000 claims 11
- 125000005915 C6-C14 aryl group Chemical group 0.000 claims 10
- 150000003839 salts Chemical class 0.000 claims 9
- 239000011780 sodium chloride Substances 0.000 claims 9
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 8
- 125000001424 substituent group Chemical group 0.000 claims 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 7
- 239000000203 mixture Substances 0.000 claims 6
- 150000002431 hydrogen Chemical class 0.000 claims 5
- 125000005914 C6-C14 aryloxy group Chemical group 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 3
- 125000004429 atoms Chemical group 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 239000001301 oxygen Chemical group 0.000 claims 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical group O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 3
- 229910052717 sulfur Chemical group 0.000 claims 3
- 239000011593 sulfur Chemical group 0.000 claims 3
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 claims 2
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 claims 2
- 125000005842 heteroatoms Chemical group 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 125000002950 monocyclic group Chemical group 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- 125000000041 C6-C10 aryl group Chemical group 0.000 claims 1
- 208000008787 Cardiovascular Disease Diseases 0.000 claims 1
- 229940012414 Factor VIIa Drugs 0.000 claims 1
- 108010054265 Factor VIIa Proteins 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 125000001769 aryl amino group Chemical group 0.000 claims 1
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 claims 1
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 1
- 230000023555 blood coagulation Effects 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000004432 carbon atoms Chemical group C* 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000000524 functional group Chemical group 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 230000028709 inflammatory response Effects 0.000 claims 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 200000000009 stenosis Diseases 0.000 claims 1
- 230000036262 stenosis Effects 0.000 claims 1
- 125000003831 tetrazolyl group Chemical group 0.000 claims 1
Claims (10)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99111109A EP1059302A1 (en) | 1999-06-08 | 1999-06-08 | Factor VIIa inhibitors |
EP99111109.7 | 1999-06-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2002100067A true RU2002100067A (en) | 2003-09-20 |
RU2248359C2 RU2248359C2 (en) | 2005-03-20 |
Family
ID=8238315
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2002100067/04A RU2248359C2 (en) | 1999-06-08 | 2000-05-27 | Inhibitors of factor viia |
Country Status (32)
Country | Link |
---|---|
US (1) | US6500803B1 (en) |
EP (2) | EP1059302A1 (en) |
JP (1) | JP4546683B2 (en) |
KR (1) | KR100979069B1 (en) |
CN (1) | CN1359390B (en) |
AR (1) | AR024292A1 (en) |
AT (1) | ATE246707T1 (en) |
AU (1) | AU774037B2 (en) |
BR (1) | BR0011461A (en) |
CA (1) | CA2376064C (en) |
CZ (1) | CZ300365B6 (en) |
DE (1) | DE60004363T2 (en) |
DK (1) | DK1189929T3 (en) |
EE (1) | EE04855B1 (en) |
ES (1) | ES2202137T3 (en) |
HK (1) | HK1047289B (en) |
HR (1) | HRP20010912B1 (en) |
HU (1) | HUP0201451A3 (en) |
IL (2) | IL146731A0 (en) |
ME (1) | MEP57708A (en) |
MX (1) | MXPA01012568A (en) |
NO (1) | NO328249B1 (en) |
NZ (1) | NZ515966A (en) |
PL (1) | PL202879B1 (en) |
PT (1) | PT1189929E (en) |
RS (1) | RS50415B (en) |
RU (1) | RU2248359C2 (en) |
SI (1) | SI1189929T1 (en) |
SK (1) | SK286902B6 (en) |
TR (1) | TR200103550T2 (en) |
WO (1) | WO2000075172A2 (en) |
ZA (1) | ZA200110053B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1059302A1 (en) * | 1999-06-08 | 2000-12-13 | Aventis Pharma Deutschland GmbH | Factor VIIa inhibitors |
DE10005631A1 (en) * | 2000-02-09 | 2001-08-23 | Max Planck Gesellschaft | Arginine Mimetics as Factor X¶a¶ Inhibitors |
GB0014134D0 (en) * | 2000-06-10 | 2000-08-02 | Astrazeneca Ab | Combination therapy |
US7001887B2 (en) * | 2001-02-02 | 2006-02-21 | Chugai Seiyaku Kabushiki Kaisha | Peptide derivatives |
GB0127615D0 (en) | 2001-07-09 | 2002-01-09 | Aventis Pharm Prod Inc | Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity |
JP5043429B2 (en) | 2003-08-18 | 2012-10-10 | ハー・ルンドベック・アクチエゼルスカベット | Succinate and malonate of trans-4-((1R, 3S) -6-chloro-3-phenylindan-1-yl) -1,2,2-trimethylpiperazine and method of use as a medicament |
TWI453198B (en) | 2005-02-16 | 2014-09-21 | Lundbeck & Co As H | Process for making the trans-1-( (1r , 3s)- 6-chloro - 3 -phenylindan-1- yl ) - 3 , 3 - dimethylpiperazine and salts thereof and for making 4 -((1r , 3s )-6- chloro- 3- phenylindan -1- yl )-1, 2 , 2 -trimethylpiperazine and salts thereof |
TWI376373B (en) | 2005-02-16 | 2012-11-11 | Lundbeck & Co As H | Crystalline base of a pharmaceutical compound |
ES2337831T3 (en) * | 2005-06-24 | 2010-04-29 | Bristol-Myers Squibb Company | USEFUL PHENYLGLYCINAMIDE AND PIRIDYLCLYCINAMIDE DERIVATIVES |
WO2007131996A1 (en) * | 2006-05-12 | 2007-11-22 | Genmedica Therapeutics Sl | Meta-xylylenediamine vanadate salts |
AU2017273857B2 (en) | 2016-06-01 | 2021-08-19 | Athira Pharma, Inc. | Compounds |
BR112021026410A2 (en) | 2019-07-01 | 2022-02-08 | Tonix Pharma Ltd | Anti-cd154 antibodies and uses thereof |
US20240059781A1 (en) | 2021-01-06 | 2024-02-22 | Tonix Pharma Limited | Methods of inducing immune tolerance with modified anti-cd154 antibodies |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5023236A (en) * | 1988-04-07 | 1991-06-11 | Corvas, Inc. | Factor VII/VIIA active site inhibitors |
US5506134A (en) | 1990-10-22 | 1996-04-09 | Corvas International, Inc. | Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex |
US5833982A (en) | 1991-02-28 | 1998-11-10 | Zymogenetics, Inc. | Modified factor VII |
US5788965A (en) | 1991-02-28 | 1998-08-04 | Novo Nordisk A/S | Modified factor VII |
SE9301916D0 (en) * | 1993-06-03 | 1993-06-03 | Ab Astra | NEW PEPTIDES DERIVATIVES |
CN1181091C (en) * | 1994-04-26 | 2004-12-22 | 西莱克泰德公司 | Factor Xa inhibitors |
PT892780E (en) * | 1996-02-22 | 2003-02-28 | Bristol Myers Squibb Pharma Co | M-AMIDINE PHENYL ANALOGS AS FACTOR XA INHIBITORS |
AR013084A1 (en) * | 1997-06-19 | 2000-12-13 | Astrazeneca Ab | USEFUL AMIDINE DERIVATIVES AS THROMBIN INHIBITORS, PHARMACEUTICAL COMPOSITION, USE OF SUCH COMPOUNDS FOR THE PREPARATION OF MEDICINES AND THE PROCESS FOR THE PREPARATION OF THE MENTIONED COMPOUNDS |
EP0987274A1 (en) * | 1998-09-15 | 2000-03-22 | Hoechst Marion Roussel Deutschland GmbH | Factor VIIa Inhibitors |
EP1059302A1 (en) * | 1999-06-08 | 2000-12-13 | Aventis Pharma Deutschland GmbH | Factor VIIa inhibitors |
-
1999
- 1999-06-08 EP EP99111109A patent/EP1059302A1/en not_active Withdrawn
-
2000
- 2000-05-27 KR KR1020017015807A patent/KR100979069B1/en not_active IP Right Cessation
- 2000-05-27 MX MXPA01012568A patent/MXPA01012568A/en active IP Right Grant
- 2000-05-27 EE EEP200100662A patent/EE04855B1/en not_active IP Right Cessation
- 2000-05-27 IL IL14673100A patent/IL146731A0/en active IP Right Grant
- 2000-05-27 CN CN008098131A patent/CN1359390B/en not_active Expired - Fee Related
- 2000-05-27 DE DE60004363T patent/DE60004363T2/en not_active Expired - Lifetime
- 2000-05-27 NZ NZ515966A patent/NZ515966A/en not_active IP Right Cessation
- 2000-05-27 WO PCT/EP2000/004846 patent/WO2000075172A2/en active IP Right Grant
- 2000-05-27 CA CA2376064A patent/CA2376064C/en not_active Expired - Fee Related
- 2000-05-27 JP JP2001502453A patent/JP4546683B2/en not_active Expired - Fee Related
- 2000-05-27 SK SK1759-2001A patent/SK286902B6/en not_active IP Right Cessation
- 2000-05-27 BR BR0011461-8A patent/BR0011461A/en active Search and Examination
- 2000-05-27 AU AU53976/00A patent/AU774037B2/en not_active Ceased
- 2000-05-27 HU HU0201451A patent/HUP0201451A3/en unknown
- 2000-05-27 ES ES00938691T patent/ES2202137T3/en not_active Expired - Lifetime
- 2000-05-27 CZ CZ20014357A patent/CZ300365B6/en not_active IP Right Cessation
- 2000-05-27 RS YUP-861/01A patent/RS50415B/en unknown
- 2000-05-27 PL PL352200A patent/PL202879B1/en not_active IP Right Cessation
- 2000-05-27 DK DK00938691T patent/DK1189929T3/en active
- 2000-05-27 SI SI200030222T patent/SI1189929T1/en unknown
- 2000-05-27 ME MEP-577/08A patent/MEP57708A/en unknown
- 2000-05-27 TR TR2001/03550T patent/TR200103550T2/en unknown
- 2000-05-27 PT PT00938691T patent/PT1189929E/en unknown
- 2000-05-27 EP EP00938691A patent/EP1189929B1/en not_active Expired - Lifetime
- 2000-05-27 AT AT00938691T patent/ATE246707T1/en active
- 2000-05-27 RU RU2002100067/04A patent/RU2248359C2/en not_active IP Right Cessation
- 2000-06-06 AR ARP000102796A patent/AR024292A1/en active IP Right Grant
- 2000-06-07 US US09/588,651 patent/US6500803B1/en not_active Expired - Lifetime
-
2001
- 2001-11-25 IL IL146731A patent/IL146731A/en not_active IP Right Cessation
- 2001-12-06 ZA ZA200110053A patent/ZA200110053B/en unknown
- 2001-12-07 HR HR20010912A patent/HRP20010912B1/en not_active IP Right Cessation
- 2001-12-07 NO NO20016005A patent/NO328249B1/en not_active IP Right Cessation
-
2002
- 2002-11-29 HK HK02108635.2A patent/HK1047289B/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2002100067A (en) | VIIA FACTOR INHIBITORS | |
RU2382042C2 (en) | New compound stimulators of growth hormone secretion | |
WO2003080580A3 (en) | Quinoline derivatives and their use as 5-ht6 ligands | |
CA2497868A1 (en) | Heterocyclic compounds | |
NO20051223L (en) | Oxadiazoles as modulators of metabotropic glutamate receptor-5. | |
MY114679A (en) | Aroyl-piperidine derivatives | |
NZ532494A (en) | Dibenzylamine compound and medicinal use thereof | |
YU79200A (en) | Therapeutic biaryl derivatives | |
HUP0402376A2 (en) | Imidazole-4-carboxamide derivatives, their preparation and pharmaceutical compositions suitable for treatment of obesity containing them | |
TW200730514A (en) | Morpholine type cinnamide compound | |
TW200621759A (en) | Novel aminopyridine derivatives having aurora A selective inhibitory action | |
RU2001103645A (en) | SERO SUBSTITUTED N-ARILAMIDES OF SULFONILAMINO-CARBOXYLIC ACID, THEIR PRODUCTION, THEIR APPLICATION AND CONTAINING THEIR PHARMACEUTICAL DRUGS | |
JP2004525117A5 (en) | ||
NO20062517L (en) | 2 cyanopyrrolidinkarboksamidforbindelse | |
ATE479690T1 (en) | THIENOÄ2,3-BÜPYRIDINE DERIVATIVES | |
HUP0204011A2 (en) | 1,2-diaryl benzimidazoles, pharmaceutical compositions containing them and their use for producing pharmaceutical compositions for treating illnesses associated with a microglia activation | |
RU2002114041A (en) | N-GUANIDINOALKYLAMIDES, THEIR PRODUCTION, THEIR APPLICATION AND THEIR PHARMACEUTICAL DRUGS | |
HUP0302604A2 (en) | Guanidine and amidine derivatives as factor xa inhibitors | |
JP2003513066A5 (en) | ||
DE602004015277D1 (en) | SUBSTITUTED 1-PHTHALAZINEAMINS AS VR-1 ANTAGONISTS | |
DK0498718T3 (en) | Use of 4- (3-trifluoromethylphenyl) -1,2,3,6-tetrahydropyridine derivatives as free radical scavengers | |
ATE24503T1 (en) | PHENYLPIPERAZINE DERIVATIVES AND PROCESS FOR THEIR MANUFACTURE. | |
RU2003128986A (en) | CARBAMATE COMPOUNDS FOR USE IN PREVENTION OR TREATMENT OF ANXIETY DISORDERS | |
NO20073736L (en) | New 3-phenylpropionic acid derivatives for the treatment of diabetes | |
RU2004126861A (en) | Pyridinamide derivatives as monoamine oxidase inhibitors (MAO-B) |